SEC Form 4 · accession 0000899243-15-009650
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Alexander
Officer — Chief Executive Officer · Director
Period of report
Dec 8, 2015
Accepted (ET)
Dec 10, 2015 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 8, 2015 | M | 17,807 | $5.616 | A | 17,807 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (ISO) | $5.616 | Dec 8, 2015 | M | 17,807 | D | Jan 25, 2015 | Jan 25, 2024 | Common Stock | 17,807 | 39,566 | D |